In 2018, ToolGen attracted around 30 billion South Korean won of investments by KTB Network, Intervest, IMM Investment, Smilegate Investment, and KB Securities. That year, the value of investments made in ToolGen was around 30 billion South Korean won. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.
Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Top owners of CRISPR patents worldwide 2019
- Premium Statistic Total number of CRISPR patent applications worldwide 1984-2018
- Premium Statistic Number of CRISPR patent applications globally by industry sector 2018
- Premium Statistic Top countries by number of CRISPR patent applications 2019
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2023-2028
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Premium Statistic Projection of top orphan drugs by global revenue 2028
- Basic Statistic Leading orphan drugs in development based on net present value 2024
About the region
10
- Premium Statistic CRISPR-Cas gene market size projections globally 2023 vs 2033
- Basic Statistic Whole exome sequencing market revenues worldwide 2018-2027
- Basic Statistic Amgen's expenditure on research and development by category 2012-2023
- Premium Statistic Top pharmaceutical R&D projects based on net present value August 2023
- Premium Statistic Top global biotech companies - R&D expenditure 2022
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Global AI-enabled drug discovery and clinical trials market by region 2030
- Basic Statistic Global next-generation sequencing market size in 2018 and 2024
- Basic Statistic Regenerative medicines market size forecast 2025
- Premium Statistic Regenerative medicines market size by therapy type forecast 2016-2025
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Basic Statistic Value of top European biotech IPOs in 2022
- Premium Statistic Value of top U.S. biotech IPOs 2022
- Basic Statistic Number of biotechnology patents in Denmark 2011-2020
- Basic Statistic Employment in California's life science industry in 2022, by sector
- Basic Statistic Swiss biotech companies: profit 2016-2023
- Premium Statistic Oncology medicines sales in Canada 2010-2019
- Premium Statistic Application number of foreign innovative drug types submitted in China 2016-2021
- Premium Statistic Opinions on integrating technology into life sciences supply chain management 2018
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Basic Statistic Share of sales attributable to new active substances launched 2016-2020 by country
Related statistics
10
- Premium Statistic Biopharmaceutical production value in South Korea 2012-2022
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on OTC pharmacy sales South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
Hankyung. (May 3, 2018). Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won) [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/
Hankyung. "Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won)." Chart. May 3, 2018. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/
Hankyung. (2018). Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won). Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/
Hankyung. "Value of Investments Made in Toolgen in South Korea from 2000 to 2018 (in Billion South Korean Won)." Statista, Statista Inc., 3 May 2018, https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/
Hankyung, Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won) Statista, https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/ (last visited June 01, 2024)
Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won) [Graph], Hankyung, May 3, 2018. [Online]. Available: https://www.statista.com/statistics/1173568/south-korea-investment-value-toolgen/